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P.berghei NK65 NYU (WT)
PbNK65S
PbNK65F
Fig. S1. CRISPR-Cas9 gene modification strategy is outlined. (A) Chromatograms showing 
the DNA sequence of the region of PBANKA_011210 ApiAP2 TF.  harboring the SNP in WT 
P.berghei ANKA and WT P.berghei NK65 NYU. (B) The design of the genetic modification 
showing the predicted alteration in gene sequence in P. berghei NK65 NYU. (C) The DNA 
sequence analysis of WT (PbNK65
S
) and Crisper Cas-9 modified (PbNK65
F
) P. Berghei NK65 


























































































































Fig. S2. The SNP in PBANKA_011210 ApiAP2 TF does not interfere with the progression 
of sexual and pre-erythrocytic stages of the P. berghei life cycle. (A) Schematic illustration of 
the experimental strategy used to address the mosquito and liver stages of the P. berghei 
infection: C57BL/6 mice were infected with 10
6





 infected donors (3 mice per group). Once parasitemia reached to 1.2%, female A. 
Stephensi mosquitos (approximately 80-100/ cup) were fed on these mice. Mosquitos that did not 
feed were removed and the remainder were kept in the incubator with frequent sucrose-water 
feeding. A portion of mosquitos were dissected at day 14 post feeding and midguts were 
visualized under microscope (B). Number of oocysts/ mosquito were counted and graphed (C). 
Each circle represents an individual mosquito. Remaining mosquitos were kept alive and 
dissected on day 21 post infection. Dissected mosquitos were pooled in groups of 10 and 
sporozoites were isolated from salivary glands. Graph show the quantification of sporozoites (D). 
Each circle represents 10 mosquitos. 5x10
3
 sporozoites were injected i.v. to C57BL/6 mice (5 per 
group) and relative amounts of parasites in liver were quantified with qPCR at 46 h post injection 
(E). Data represents two independent experiments. Lines in each graph indicate means. (n.s.= 











































































































































Fig. S3. Flow cytometry gating strategy. (A) Stepwise gating strategy used to identify the 
populations in (Fig. 3). (B) Graphs showing the actual numbers of different CD8
+
 T cell subsets 
of infected mice from the experiment outlined in (Fig. 3A-C). Each circle represents an 
individual mouse. Bars show the mean values.  (n.s.= p>0.05) Welch’s t-test.) (C) Serum IL-10 



























Days (post infection / reinfection)
C






































































































































. (A-B) Representative 
graphs showing relative serum levels of parasite specific and self-reactive IgG2b (A) and IgG2c 
(B) antibodies at day 19 post infection in mice from the experiment outlined in Fig.5 Bars and 
error bars indicate mean and standard error of the mean respectively (***=0.0001<p≤0.001; 
****= p≤0.0001) (One Way ANOVA with Tukey’s multiple comparisions test). (C)Parasitemia 





 parasites at 10
2
 infected RBC per mouse. 
 
Table S1. Summary of changes observed between the WT and CRISPR-Cas9–mutated 





A G CRISPR MUTATION (SILENT)
T C CRISPR MUTATION (SILENT)
A C CRISPR MUTATION (SILENT)
A G CRISPR MUTATION (SILENT)
C A CRISPR MUTATION (SILENT)
A G CRISPR MUTATION (SILENT)
A C CRISPR MUTATION (SILENT)
A C CRISPR MUTATION (SILENT)
A C CRISPR MUTATION (SILENT)












Supplementary information 2 
 
The 900-nucleotide synthetic sequence of AP2 (PBANKA_011210) gene 
The following 900-nucleotides were used, as homology arm, for editing the AP2 gene in P. 































The underlined sequences are the restriction sites for NcoI and XhoI, respectively that were used 
to sub-clone the homology arm in the pYC plasmid. The nucleotides in red corresponds to the 
5467-5469 position in the mRNA sequence of the AP2 gene. The nucleotides highlighted in red 
and underlined are shield mutations introduced to avoid repeated cutting of the edited locus by 
the Cas9 endonuclease. 
